Relationship between lymphocyte recovery, relapse and survival post-allogeneic stem cell transplantation in children with acute lymphatic and myeloid leukemia.

被引：0
|
作者：
Vowels, MR
Chiou, SS
Oswald, C
Ford, D
机构：
[1] Sydney Childrens Hosp, Ctr Childrens Canc, Randwick, NSW, Australia
[2] Prince Wales Hosp, Bone Marrow Transplant Lab, Randwick, NSW 2031, Australia
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1662
引用
收藏
页码：429A / 429A
页数：1
相关论文
共 50 条
  • [31] Effective treatment with imatinib mesylate and donor lymphocyte infusion following relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia.
    Li, JY
    Wu, HX
    Qian, SX
    Hong, M
    Xiao, B
    Zhang, R
    Ruan, CG
    BLOOD, 2005, 106 (11) : 441B - 441B
  • [32] Slow lymphocyte recovery predicts increased risk for relapse after allogeneic bone barrow transplantation for acute lymphocytic leukemia.
    Kumar, S
    Lacy, MQ
    Inwards, DJ
    Tefferi, A
    Gastineau, DA
    Gertz, MA
    Litzow, MR
    BLOOD, 2001, 98 (11) : 368B - 368B
  • [33] Prognostic Impact of Circulating Tumor DNA Status Post-Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Nakamura, Sousuke
    Yokoyama, Kazuaki
    Shimizu, Eigo
    Yusa, Nozomi
    Ogawa, Miho
    Takei, Tomomi
    Kobayashi, Asako
    Ito, Mika
    Isobe, Masamichi
    Konuma, Takaaki
    Kato, Seiko
    Kasajima, Rika
    Wada, Yuka
    Nagamura-Inoue, Tokiko
    Yamaguchi, Rui
    Takahashi, Satoshi
    Imoto, Seiya
    Miyano, Satoru
    Tojo, Arinobu
    BLOOD, 2018, 132
  • [34] Extramedullary Leukemia Relapse In Patients With Acute Myeloid Leukemia Allogeneic Stem Cell Transplantation: Risk Factors and Prognosis
    Gupta, Vinay
    Gundabolu, Krishna
    Gonsalves, Wilson I.
    Litzow, Mark R.
    Hogan, William J.
    Gangat, Naseema
    Patnaik, Mrinal M.
    BLOOD, 2013, 122 (21)
  • [35] Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation
    Minculescu, Lia
    Reekie, Joanne
    Petersen, Soeren Lykke
    Kornblit, Brian Thomas
    Schjoedt, Ida
    Andersen, Niels Smedegaard
    Andersen, Lisbeth Pernille
    Fischer-Nielsen, Anne
    Haastrup, Eva Kannik
    Friis, Lone Smidstrup
    Sengelov, Henrik
    ACTA HAEMATOLOGICA, 2023, : 325 - 332
  • [36] Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation
    Minculescu, Lia
    Reekie, Joanne
    Petersen, Soren Lykke
    Kornblit, Brian Thomas
    Schjodt, Ida
    Andersen, Niels Smedegaard
    Andersen, Lisbeth Pernille
    Fischer-Nielsen, Anne
    Hastrup, Eva Kannik
    Friis, Lone Smidstrup
    Sengeloev, Henrik
    BLOOD, 2021, 138
  • [37] Allogeneic stem cell transplantation in the management of acute myeloid leukemia
    Schmid, Christoph
    Kolb, Hans-Jochem
    MEDIZINISCHE KLINIK, 2007, 102 (04) : 317 - 323
  • [38] Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia In Reply
    Zander, Axel R.
    Bacher, Ulrike
    Finke, Juergen
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2009, 106 (06): : 98 - 98
  • [39] Effect of combined lymphocyte and monocyte recovery on survival post myeloablative allogeneic hematopoietic stem cell transplant for acute leukemia
    Thoma, M.
    Huneke, T.
    DeCook, L.
    Johnson, N.
    Wiegand, R.
    Litzow, M. R.
    Hogan, W. J.
    Porrata, L. F.
    Holtan, S. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission
    Fagioli, Franca
    Zecca, Marco
    Locatelli, Franco
    Lanino, Edoardo
    Uderzo, Cornelio
    Di Bartolomeo, Paolo
    Berger, Massimo
    Favre, Claudio
    Rondelli, Roberto
    Pession, Andrea
    Messina, Chiara
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30 (08) : 575 - 583
12345